NCT03746548

Brief Summary

Patients with conductive hearing loss fitting the inclusion criteria will be asked to participate in the study. All subjects will be randomized to wear either first the adhesive or the conventional bone conduction hearing aid. They will wear either device for two weeks. They will use the second device for another two weeks. Audiologic tests and quality of life questionnaires will be assessed at the beginning of the study after two weeks with the first device and after two weeks with the second device. Additionally, all patients will be asked to keep a diary including daily wearing time of the device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 19, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

January 2, 2020

Status Verified

December 1, 2019

Enrollment Period

1.1 years

First QC Date

November 11, 2018

Last Update Submit

December 28, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Wearing time

    Wearing time per day of the two devices

    1 year

Study Arms (2)

CM-ADHEAR

OTHER

First patients use the Contact Mini (conventional bone conduction device used with a soft band or headband) then ADHEAR (adhesive bone conduction device)

Device: AdhearDevice: Contact Mini (CM)

ADHEAR - CM

OTHER

First patients use ADHEAR (adhesive bone conduction device) then CM (conventional bone conduction device used with a soft band or headband)

Device: AdhearDevice: Contact Mini (CM)

Interventions

AdhearDEVICE

Patients are wearing the Adhesive bone conduction hearing device (Adhear) for 2 weeks

ADHEAR - CMCM-ADHEAR

Patients are wearing the Conventional bone conduction hearing device (Contact Mini) for 2 weeks

ADHEAR - CMCM-ADHEAR

Eligibility Criteria

Age13 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral and/or bilateral conductive hearing loss (CHL)
  • The bone conduction threshold for the patient's affected ear shall be better than or equal to 25 dB HL (PTA BC for 0.5, 1, 2, 3 kHz).
  • Subjects aged 13 years or older
  • Capable of the German language
  • Willingness and ability to perform all tests required for the study
  • Signed, and dated informed consent before the start of any study specific procedure

You may not qualify if:

  • Pregnancy or breastfeeding
  • Patient is intolerant of the materials as described by Manufacturer's IFU
  • Patient presents with a skin or scalp condition that may preclude the attachment of the adhesive adapter.
  • Patient cannot perform the audiological tests or is unable to fill out the questionnaires.
  • Patient presents with retrocochlear, or central auditory disorder.
  • any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MUW AKH

Vienna, 1090, Austria

Location

MeSH Terms

Conditions

Hearing Loss, Conductive

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assoc. Prof. PD. Dr.

Study Record Dates

First Submitted

November 11, 2018

First Posted

November 19, 2018

Study Start

January 1, 2018

Primary Completion

February 18, 2019

Study Completion

June 30, 2019

Last Updated

January 2, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations